{"id":"W1990481620","doi":"10.1097/01.mou.0000175572.46986.2c","title":"Antisense oligonucleotide therapy in the management of bladder cancer","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Antisense therapy; Bladder cancer; Oligonucleotide; Cancer; In vivo; Genetic enhancement; Cancer research; Urinary system; Internal medicine; Biology; Locked nucleic acid; Gene; Biotechnology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002218727,0.0003520653,0.001214996,0.0003182573,0.00001870137,0.00000569717,0.0002582608,0.0001934384,0.0003270891],"category_scores_gemma":[0.0000035258,0.0002201914,0.0002740462,0.0004432465,0.0001005572,0.00002513105,0.00005302555,0.0005056868,0.00004330149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001102477,"about_ca_system_score_gemma":0.0001799654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006045824,"about_ca_topic_score_gemma":0.00001158829,"domain_scores_codex":[0.9980381,0.0002653135,0.0007074142,0.0004220525,0.0002264978,0.0003406374],"domain_scores_gemma":[0.9991424,0.00007730674,0.0002344131,0.0004751827,0.00002636189,0.00004433685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000731788,0.0005307257,0.0004064965,0.005994073,0.0002754759,0.00001644752,0.0001500935,0.000002603693,4.105571e-8,0.0002145421,0.001732386,0.9906039],"study_design_scores_gemma":[0.001911129,0.0002450834,0.002675343,0.005397663,0.0003428031,0.00004523628,0.00001754566,0.000003235397,1.97841e-7,0.00003176254,0.9891791,0.0001508706],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008334836,0.9942068,0.000003114159,0.0003315709,0.002500537,0.001825976,0.00004527809,0.00001273528,0.0009906213],"genre_scores_gemma":[0.000361644,0.9981508,0.00002052652,0.0001327796,0.0005289136,0.00062309,0.0001036763,0.00003883488,0.00003975383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9904531,"threshold_uncertainty_score":0.8979144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1447929501662539,"score_gpt":0.4494625595887894,"score_spread":0.3046696094225356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}